Characterization and determinants of an electronegatively charged low-density lipoprotein in human plasma

References

• Steinberg D. and Workshop Participants. Antioxidants in the prevention of human atherosclerosis. Circulation 1992; 85: 2337–44
   PubMed Web of Science ®Google Scholar
• Halliwell B. Free radicals, antioxidants, and human disease: curiosity, muse, or consequence?. Lancet 1994; 344: 721–4
   PubMed Web of Science ®Google Scholar
• Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793–5
   PubMed Web of Science ®Google Scholar
• Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992; 339: 883–7
   PubMed Web of Science ®Google Scholar
• Maggi E, Chiesa R, Melissano G, Castellano R, Astore D, Grossi A, et al. LDL oxidation in patients with severe carotid atherosclerosis: a study ofin vitro and in vivooxidation markers. Arterioscler Thromb 1994; 14: 1892–9
   PubMed Web of Science ®Google Scholar
• Cazzolato G, Avogaro P, Bittolo-Bon G. Characterization of a more ebctronegatively charged LDL subfraction by ion exchange HPLC. Free Rad Biol Med 1991; 11: 247–53
   PubMed Web of Science ®Google Scholar
• Vedie BI, Myara I, Pech MA, Maziere JC, Maziere C, Caprani A, et al. Fractionation of charge-modified low-density lipoproteins by fast protein liquid chromatography. J Lipid Res 1991; 32: 1359–69
   PubMed Web of Science ®Google Scholar
• Nyyssönen K, Salonen JT. Comparison of gel permeation chromatography, density gradient ultracentrifugation and precipitation methods for quantitation of very-low, low- and high-density lipoprotein cholesterol. J Chromatogr 1991; 570: 382–9
   PubMedGoogle Scholar
• Baker MA, Cerniglia JC, Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem 1990; 190: 360–5
   PubMed Web of Science ®Google Scholar
• Thurnham DI, Smith E, Flora PS. Concurrent liquid-chromatogaphc assay of retinol, α-tocopherol, β-carotene, α-carotene, lycopene, and β-cryptoxanthin in plasma, with tocopherol acetate as internal standard. Clin Chem 1988; 34: 377–81
   PubMed Web of Science ®Google Scholar
• Nyyssonen K, Porkkala E, Salonen R, Korpela H, Salonen JT. Increase in oxidation resistance of atherogenic serum lipoproteins following antioxidant supplementation: a randomized double-blind placebo-controlled trial. Eur J Clin Nutr 1994; 48: 633–42
   PubMed Web of Science ®Google Scholar
• Parviainen MT, Nyyssönen K, Penttilä IM, Seppänen K, Rauramaa R, Salonen JT, et al. A method for routine assay of plasma ascorbic acid using high-performance liquid chromatography. J Liq Chromatogr 1986; 9: 2185–97
   Web of Science ®Google Scholar
• Berliner JA, Territo MC, Sevanian A, Ramin S, Ai Kim J, Bamshad B, et al. Minimally modified low density lipoprotein stimulates rnonocyte endothelial interactions. J Clin Invest 1991; 85: 1260–6
   Google Scholar
• Liao F, Berliner JA, Mehrabian M, Navab M, Demer LL, Lusis AJ, et al. Minimally modified low density lipoprotein is biologically activein vivoin mice. J Clin Invest 1991; 87: 2253–7
   PubMed Web of Science ®Google Scholar
• Mahley RW, Innerarity TL, Weisgraber KH, Oh SY. Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins. J Clin Invest 1979; 64: 743–50
   PubMed Web of Science ®Google Scholar
• Fogelman AM, Sechter I, Seager J, Hokom M, Child JS, Edwards PA. Malondialdehyde alteration of low density lipoprotein leads to cholesteryl ester accumulation in human monocyte-macrophages. Roc Natl Acad Sci USA 1980; 77: 2214–18
   PubMed Web of Science ®Google Scholar
• Bittolo Bon G, Cazzolato G, Avogaro P. Does a circulating oxidized LDL exist and can it be detected?. Free radicals, lipoprotein oxidation and atherosclerosis: biological and clinical aspects, G Bellomo, G Finardi, E Maggi, C Rice-Evans. Richelieu Press, London 1995; 205–28
   Google Scholar
• Avogaro P, Bittolo Bon G, Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis 1988; 8: 79–87
   PubMedGoogle Scholar
• Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parathasarathy S, Carew TE, Butler S, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989; 84: 1086–95
   PubMed Web of Science ®Google Scholar
• Meister A. Glutathione, ascorbate, and cellular protection. Cancer Res 1994; 54: 1969–75
   PubMed Web of Science ®Google Scholar
• Jialal I, Grundy SM. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. J Clin Invest 1991; 87: 597–601
   PubMed Web of Science ®Google Scholar
• De Graaf J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendriks JCM, Stalenhoef AFH. Enhanced susceptibility toin vitrooxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991; 11: 298–306
   PubMed Web of Science ®Google Scholar
• Demuth K, Myara I, Chappey B, Vedie B, Pech-Amsellem MA, Haberland ME, et al. A cytotoxic electronegative LDL subfraction is present in human plasma. Arterioscl Thromb Vasc Biol 1996; 16: 773–83
   PubMed Web of Science ®Google Scholar